Skip to main content
. 2018 Jul 16;8:10713. doi: 10.1038/s41598-018-28281-5

Figure 7.

Figure 7

Comparison of the effects of the intranasal (IN) and intramuscular (IM) immunisation routes on EV71-specific antibody titres and cytokine production. Mice were IN or IM immunised with PBS or formalin-inactivated EV71 (5 μg/dose) alone or adjuvanted with CpG (20 μg/dose) three times at 3-week intervals. ELISA was used to measure EV71-specific IgA in the nasal wash (a), BALF (b), faeces (c), and serum (d) and EV71-specific IgG in the serum (e) of mice at 2 weeks after the third immunisation. Splenocytes from immunised mice were harvested and cultured for 2 days in medium containing 10 μg/mL heat-inactivated EV71, after which culture supernatants were analysed for IFN-γ (f), IL-4 (g), and IL-17 (h) using ELISA. One representative study of two with similar results is shown. Values shown are means ± SEMs of five mice in each experimental group; *p < 0.05, **p < 0.01, ***p < 0.001. BALF: bronchoalveolar lavage fluid.